Literature DB >> 12371127

Clinicopathological study of involvement of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor in non-lymphohematopoietic malignant tumors accompanied by leukocytosis.

K Kojima1, F Nakashima, A Boku, Y Muroishi, I Nakanishi, Y Oda.   

Abstract

Involvement of granulocyte colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) in non-lymphohematopoietic malignant tumors accompanied by leukocytosis was clinicopathologically investigated. Among 1,778 autopsy cases in the last 20 years, 485 lesions of 439 cases with non-lymphohematopoietic malignant tumors accompanied by leukocytosis with a white blood cell count of 10,000/mm3 or greater during the course were immunohistologically examined for G-CSF and GM-CSF. Three (0.7%) and two cases (0.5%) were G-CSF- and GM-CSF-positive, respectively. GM-CSF mRNA was confirmed by using non-fixed cryopreserved tumor tissues in one case positive for GM-CSF. G-CSF-positive cases were large cell carcinoma of the lung, adenocarcinoma of the colon, and adenocarcinoma of the stomach, and GM-CSF-positive cases were spindle cell carcinoma of the lung and malignant thymoma. In the case with stomach carcinoma, the primary lesion showing moderately differentiated adenocarcinoma was negative, but the lung metastatic lesion showing less differentiated adenocarcinoma was G-CSF-positive. The survival period was six months or less in four out of five positive cases. The highest white blood cell count in five CSF-positive cases was markedly elevated: 29,400-103,500/mm3 (mean: 59,700/mm3). In four cases, excluding one case which may have been markedly affected by chemotherapy, the bone marrow showed hyperplasia, and the number of the granulocyte series cells significantly increased. There were three cases (0.7%) negative for both G-CSF and GM-CSF, although they showed marked leukocytosis (60,000/mm3 or higher) which were higher than the mean count of CSF-positive cases and was not observed in autopsy cases with non-tumorous diseases. Other stimulating factors may be involved in the development of leukocytosis in such cases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12371127     DOI: 10.14670/HH-17.1005

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  12 in total

Review 1.  Aggressive recurrence of gastric cancer as a granulocyte-colony-stimulating factor-producing tumor.

Authors:  Masahiko Kawaguchi; Yasuyuki Asada; Takuro Terada; Akira Takehara; Yoshinori Munemoto; Katsunori Fujisawa; Takeshi Mitsui; Yoshiro Iida; Shoji Miura; Yoshiko Sudo
Journal:  Int J Clin Oncol       Date:  2010-02-24       Impact factor: 3.402

2.  Aggressive undifferentiated colon carcinoma producing granulocyte-colony stimulating factor: report of a case.

Authors:  Akihisa Matsuda; Koji Sasajima; Takeshi Matsutani; Hiroshi Maruyama; Masayuki Miyamoto; Tadashi Yokoyama; Seiji Suzuki; Hideyuki Suzuki; Takashi Tajiri
Journal:  Surg Today       Date:  2009-11-01       Impact factor: 2.549

3.  Granulocyte colony-stimulating factor-producing undifferentiated carcinoma of the colon mimicking a pulmonary giant cell carcinoma: a case showing overexpression of CD44 along with highly proliferating nestin-positive tumor vessels.

Authors:  Shogo Tajima; Michihiko Waki; Tomonori Tsuchiya; Shoji Hoshi
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

4.  Dedifferentiated chondrosarcoma with leukocytosis and elevation of serum G-CSF. A case report.

Authors:  Akio Sakamoto; Hidetaka Yamamoto; Kazuhiro Tanaka; Shuichi Matsuda; Katsumi Harimaya; Yoshinao Oda; Masazumi Tsuneyoshi; Yukihide Iwamoto
Journal:  World J Surg Oncol       Date:  2006-07-04       Impact factor: 2.754

5.  Hematological response of topotecan in tumor-bearing rats: modeling of the time course of different cellular populations.

Authors:  Cristina Segura; Eva Bandrés; Iñaki F Trocóniz; Jesús García-Foncillas; Onintza Sayar; Carmen Dios-Vieítez; Maria Jesús Renedo; María J Garrido
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

6.  Granulocyte-colony stimulating factor (G-CSF) producing malignant pleural mesothelioma: Report of a case.

Authors:  Ayako Fujiwara; Masahiko Higashiyama; Takashi Kanou; Jiro Okami; Toshiteru Tokunaga; Yasuhiko Tomita; Ken Kodama
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

7.  LPS-Induced G-CSF Expression in Macrophages Is Mediated by ERK2, but Not ERK1.

Authors:  Shwu-Fen Chang; Shih-Shan Lin; Hui-Ching Yang; Yuan-Yi Chou; Jhen-I Gao; Shao-Chun Lu
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

8.  Systemic chemotherapy with pronounced efficacy and neutropenia in a granulocyte-colony stimulating factor-producing advanced gastric neuroendocrine carcinoma.

Authors:  Nobuhiro Tsuruta; Kotoe Takayoshi; Shuji Arita; Tomomi Aikawa; Hiroshi Ariyama; Hitoshi Kusaba; Kenoki Ohuchida; Eishi Nagai; Kenichi Kohashi; Minako Hirahashi; Kyoko Inadomi; Mamoru Tanaka; Kosuke Sagara; Yuta Okumura; Kenta Nio; Michitaka Nakano; Masafumi Nakamura; Yoshinao Oda; Koichi Akashi; Eishi Baba
Journal:  Oncol Lett       Date:  2017-06-02       Impact factor: 2.967

9.  Paraneoplastic Leukemoid Reaction in Gastroesophageal Junction Adenocarcinoma: A Case Report.

Authors:  Kevin Wei-Lun Chang; Lai Lai Kwok; Manish K Rana; Sapna Patel; Thomas Birris
Journal:  Am J Case Rep       Date:  2020-01-31

10.  Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy.

Authors:  Antoine Schernberg; Pierre Blanchard; Cyrus Chargari; Dan Ou; Antonin Levy; Philippe Gorphe; Ingrid Breuskin; Sarah Atallah; Alexandre Caula; Alexandre Escande; François Janot; France Nguyen; Stéphane Temam; Eric Deutsch; Yungan Tao
Journal:  Clin Transl Radiat Oncol       Date:  2018-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.